Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The new credit card-size rapid antigen test can return results in 15 minutes.
“The SalivaDirect test...is yet another testing innovation game changer that will reduce the demand for scarce testing resources.”
The American Cancer Society now calls for vaccination of girls and boys starting at age 9.
The nondrug is intended to improve the ability of children to pay attention, stay focused and control their behavior.
The FDA approved Oriahnn capsules for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Selpercatinib, the first drug in its class, shrank tumors in over two thirds of previously treated patients.
Tests like the one approved this week can show who is likely to be immune, but it’s not yet clear how long such immunity lasts.
Children are exposed to controlled amounts of Palforzia until they can tolerate the dosage needed to avoid severe allergic reactions.
Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.
The new indication is for prevention of sexually transmitted HIV, with the exception of transmission via receptive vaginal sex.
AACR report highlights progress in preventing and treating cancer—including 27 new drug approvals last year—but disparities persist.
Off-label drug use for respiratory infections, asthma or mental health disorders in children is on the rise.
Pretomanid triple therapy cuts the length of treatment from 18 months to six months.
Previously, tests were approved only for use with genital or urine samples.
Eighty percent of medications that receive accelerated approval don’t extend overall survival.
Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.